Finance

EpicQuest Education discloses Nasdaq listing deficiency notice

EpicQuest Education Receives Delinquency Notice from Nasdaq EpicQuest Education (EEIQ), a company listed on the Nasdaq Capital Market, has recently received a delinquency notification letter...

JonesTrading Remains a Buy on EyePoint Pharmaceuticals (EYPT)

Analyst Report Highlights: EyePoint Pharmaceuticals (EYPT) Maintains Buy Rating In a recent report released today, analyst Debanjana Chatterjee from JonesTrading reaffirmed her optimistic outlook on...

Truist Savings Rates: Features, Benefits, and Rates

Truist Bank Savings Accounts: A Comprehensive Review and Comparison Introduction Truist Bank, a prominent name in personal loans and mortgages, has been evaluated by Business Insider's...

Understanding Second Home Mortgage Rates: a Comprehensive Guide

Is Now the Time to Invest in Your Dream Second Home? A Comprehensive Guide Understanding Second Home Mortgage Rates If you're considering purchasing a second home...

Arena Group names Paul Edmondson CEO

A New Era of Leadership at The Arena Group: The Appointment of Paul Edmondson as CEO In a strategic move to steer the company toward...

a Simple Way to Invest Through Ups and Downs

What is Dollar-Cost Averaging? Dollar-cost averaging is a widely used investment strategy designed to help investors reduce the impact of volatility in the stock market....

Canaccord Genuity Reaffirms Their Buy Rating on Parkit Enterprise (PKTEF)

Analyst Rating and Price Target Canaccord Genuity analyst Mark Rothschild has reaffirmed his confidence in Parkit Enterprise (PKTEF) by maintaining a "Buy" rating on the...

Today’s ARM Rates

Adjustable-Rate Mortgages (ARMs): A Comprehensive Guide to Understanding Their Benefits, Risks, and Current Trends Introduction to Adjustable-Rate Mortgages (ARMs) Adjustable-rate mortgages, or ARMs, are a type...

Mantle Ridge establishes more than $1B Cognizant stake, WSJ reports

The Rise of Activist Investors: How Mantle Ridge is Betting Big on Cognizant Introduction to Activist Investing: A Powerful Force in Corporate Governance In the dynamic...

DexCom receives warning letter from FDA, sees no impact to FY25 guidance

Introduction In a recent regulatory filing, DexCom (DXCM) revealed that it received a warning letter from the U.S. Food and Drug Administration (FDA) on March...

Related Posts